Size of colorectal liver metastases at abdominal CT: comparison of precontrast and postcontrast studies.
OBJECTIVE
To investigate whether measurements of hepatic metastases from colorectal carcinoma before contrast material administration are significantly different statistically from measurements after contrast material administration.


METHODS
Twenty-four patients with hepatic metastases from colorectal carcinoma underwent spiral computed tomography (CT) with 7-mm collimation. The liver was imaged before and in the portal-dominant phase after intravenous contrast material administration. For each scan, one to three discrete liver lesions were selected for measurement (n = 49). Three experienced radiologists performed independent measurements of the selected lesions on both pre- and postcontrast images at a computer workstation. A three-way analysis of variance (ANOVA) was performed: subjects by raters (the three independent radiologists) by pre- or postcontrast status. The dependent variable was the product of bidimensional measurements.


RESULTS
Sixty-seven percent (33 of 49) of the lesions were measured as larger on precontrast images; 33% (16 of 49), as smaller. There was high interrater reliability, with an intraclass correlation coefficient greater than 0.9 ANOVA showed significant subject, rater, and contrast material effects (P < .001) for the largest lesions in each liver. Contrast material status was a significant factor for all lesion sizes (P < .003).


CONCLUSIONS
On average, hepatic metastases from colorectal carcinoma are significantly smaller after contrast material administration.
Nazarian
L N
LN
Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, PA 19107-5244, USA.
Park
J H
JH
Halpern
E J
EJ
Parker
L
L
Johnson
P T
PT
Lev-Toaff
A S
AS
Wechsler
R J
RJ
D000328:Adult; D000368:Aged; D001466:Barium Sulfate; D015179:Colorectal Neoplasms / Q000000981:diagnostic imaging*; D003287:Contrast Media; D003973:Diatrizoate; D003974:Diatrizoate Meglumine; D005260:Female; D006801:Humans; D007482:Iothalamate Meglumine; D008099:Liver / Q000000981:diagnostic imaging; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed; D014283:Triiodobenzoic Acids
D003287:Contrast Media; D014283:Triiodobenzoic Acids; D003973:Diatrizoate; D001466:Barium Sulfate; D003974:Diatrizoate Meglumine; C054871:ioversol; D007482:Iothalamate Meglumine